WORLD
Currently, Tocilizumab is Expensive and in Short Supply Globally. WHO and Partners Are ... - Latest Tweet by World Health Organization
The latest Tweet by World Health Organization states, 'Currently, tocilizumab is expensive and in short supply globally. WHO and partners are currently discussing lower prices and improved access in low- and middle-income countries with the producer. More info 👉...'
Currently, tocilizumab is expensive and in short supply globally. WHO and partners are currently discussing lower prices and improved access in low- and middle-income countries with the producer.
More info 👉https://t.co/yKLEAXCUtu— World Health Organization (WHO) (@WHO) February 11, 2022
(The above story first appeared on LatestLY on Feb 11, 2022 11:42 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
